Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer.

Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer.
复制标题

DOI:
10.18632/oncotarget.3166
复制
发表时间:
2015-03-30
期刊:
影响因子:
--
通讯作者:
Chen X
Chen X
中科院分区:
其他
文献类型:
--
作者:
Tao J;Ji J;Li X;Ding N;Wu H;Liu Y;Wang XW;Calvisi DF;Song G;Chen X

文献摘要

参考文献

被引文献

相似文献

Deregulation of microRNAs (miRNAs) is a typical feature of human hepatocellular carcinoma (HCC). However, the in vivo relevance of miRNAs along hepatocarcinogenesis remains largely unknown. Here, we show that liver tumors induced in mice by c-Myc overexpression or AKT/Ras co-expression exhibit distinct miRNA expression profiles. Among the downregulated miRNAs, eight (miR-101, miR-107, miR-122, miR-29, miR-365, miR-375, miR-378, and miR-802) were selected and their tumor suppressor activity was determined by overexpressing each of them together with c-Myc or AKT/Ras oncogenes in mouse livers via hydrodynamic transfection. The tumor suppressor activity of these microRNAs was extremely heterogeneous in c-Myc and AKT/Ras mice: while miR-378 had no tumor suppressor activity, miR-107, mir-122, miR-29, miR-365 and miR-802 exhibited weak to moderate tumor suppressor potential. Noticeably, miR-375 showed limited antineoplastic activity against c-Myc driven tumorigenesis, whereas it strongly inhibited AKT/Ras induced hepatocarcinogenesis. Furthermore, miR-101 significantly suppressed both c-Myc and AKT/Ras liver tumor development. Altogether, the present data demonstrate that different oncogenes induce distinct miRNA patterns, whose modulation differently affects hepatocarcinogenesis depending on the driving oncogenes. Finally, our findings support a strong tumor suppressor activity of miR-101 in liver cancer models regardless of the driver oncogenes involved, thus representing a promising therapeutic target in human HCC.
DOI: 10.1053/j.gastro.2011.12.061
发表时间: 2012-05
期刊: Gastroenterology
影响因子: 29.4
作者:
El-Serag HB
通讯作者: El-Serag HB
DOI: 10.1158/0008-5472.can-10-3367
发表时间: 2011-03-15
期刊: Cancer research
影响因子: 11.2
作者:
Cao Z;Fan-Minogue H;Bellovin DI;Yevtodiyenko A;Arzeno J;Yang Q;Gambhir SS;Felsher DW
通讯作者: Felsher DW
DOI: 10.1634/theoncologist.2008-0185
发表时间: 2009-01-01
期刊: ONCOLOGIST
影响因子: 5.8
作者:
Kane, Robert C.;Farrell, Ann T.;Pazdur, Richard
通讯作者: Pazdur, Richard
DOI: 10.1056/nejmoa0708857
发表时间: 2008-07-24
影响因子: 158.5
作者:
Llovet, Josep M.;Ricci, Sergio;Bruix, Jordi
通讯作者: Bruix, Jordi
DOI: 10.1056/nejmoa0901282
发表时间: 2009-10-08
期刊: The New England journal of medicine
影响因子: --
作者:
Ji J;Shi J;Budhu A;Yu Z;Forgues M;Roessler S;Ambs S;Chen Y;Meltzer PS;Croce CM;Qin LX;Man K;Lo CM;Lee J;Ng IO;Fan J;Tang ZY;Sun HC;Wang XW
通讯作者: Wang XW